mikroorganismer - agropro
TRANSCRIPT
Mikroorganismer Fremtidens arbejdskraft
Tina Sejersgård Fanø EVP, Agriculture and Bioenergy Planteavlsdag 2017
2
Novozymes at a glance
World leader in Bioinnovation
Listed 2000
Ticker NZYM B
Exchange Nasdaq Copenhagen
CEO Peder Holk Nielsen
(since 2013)
• ~6,500 employees
• ~700 products sold in 140 countries
• Major production footprint in 3 regions
Global
Profitable
Majority owner Novo A/S
R&D intensive
• ~1,400 people employed in R&D
• ~7,000 patents
• ~ 13% of sales invested in R&D
• Innovation focused on enzymes and microbes
• Controls 25.5% of the capital
• ~70% of the votes
• 2 seats on the board of directors
11,234 11,746
12,459
14,002 14,142
20%
22%
24%
26%
28%
30%
32%
34%
36%
2012 2013 2014 2015 2016
EBIT margin
• USD 2bn in sales
• ~28% EBIT margin
• ~25% ROIC
DK
Km
5 years of organic growth & EBIT
+4% +7% +7% +4% +2%
Market Leader in industrial enzymes • ~48% Novozymes
• ~19% DuPont
• ~33% Others incl. DSM, Chinese, captive etc.
Company background
2 LATEST RESULTS • OVERVIEW AND STRATEGY • MARKET OVERVIEW • SUSTAINABILITY • FINANCIALS AND GOVERNANCE
3
A unique partnership combing Novozymes’ and Monsanto’s world class capabilities forming the industry's most advanced microbial platform
A premier vehicle for bringing microbes to market and a sustainable Agriculture platform for farmers to produce more
with less
A joint focus to transition this small niche into mainstream Ag practice
The Novozymes – Monsanto BioAg Alliance
4
ESTABLISHED MICROBIAL LEADERSHIP INDUSTRY-LEADING R&D CAPABILITY AND COMMERCIAL FOOTPRINT
REGULATORY
REGISTRATIONS
PROCESS
OPTIMIZATION
Extensive microbial library
Strain optimization & formulation
World-class fermentation
Existing microbial products
Unique microbial library
Leading field testing network
Global commercial footprint
Ability to unlock placement with precision
agriculture
The BioAg Alliance
+
DIS
CO
VE
RY
COMMERCIALIZATION
MANUFACTURING SELECTED
MICROBES CUSTOMERS
FIELD
TESTING
SMALL-SCALE
FERMENTATION
DISCOVERY
COLLABORATIONS
IN-LICENSING PRODUCTS &
COMPLEMENTARY TECHNOLOGIES
OUT-LICENSING
OPPORTUNITIES
BioAg Alliance: Initiation 2014 Establishment of Alliance in 2014 to drive microbials as
industry platform for next wave of yield and sustainability solutions
Leveraging Alliance Capabilities and
Establishing Microbial Platform of
Seed Applied Solutions for Core
Crops of Corn, Soy, Wheat and
Canola/OSR
MA
RK
ET
RE
AC
H
Expanding Market Opportunity
including Fruits & Vegetables,
Rice, Cotton and Improved
Core Crop Products
NEAR-TERM MID-TERM LONG-TERM
Precision Agriculture
focusing on advanced
microbial solutions with
significant product offerings
BioAg Alliance Opportunity Began in 2014 with the goal of transitioning Ag Microbials from an Ag niche into mainstream Ag practice
5
+260bn USD market potential driven by favorable underlying mega trends
6
RISING
population
1980
4.4B
TODAY
7.1B
2050
9.6B+
CHANGING
economies & diets
9% in 1965
14% in 2030
DIETARY PERCENTAGE OF MEAT
DECLINING
arable land
1 ACRE per person in
1961
less than
1/3 ACRE per person in
2050
54
185
20
Market size of
>260bn USD
Crop Protection Yield Fertilizer CROP PRODUCTION WILL NEED TO DOUBLE
BY 2050
Main challenges within BioAg
Growth Barriers
• Unclear regulatory environments
• Need for education of stakeholders
regarding this long-term sustainable
production method
• Biotechnology solutions at relatively early
stage of development
• Technology robustness
There are approximately
in 1 tablespoon of soil1
Microbial solutions for agriculture
Microbials, notably bacteria and fungi, are types of agricultural biologicals that protect crops from pests and diseases and enhance plant productivity and fertility.
8
1. North Carolina State
University Cooperative
Extension
How are microbials applied?
Seed treatment
Foliar
In-furrow
BioControl
• Complements or potentially replaces
chemical pesticides
• Provides additional modes of action
BioYield
• Utilizes nutrients in the soil
• Creates stronger, healthier plants
• Provides new options for sustainable
agriculture
Integrated solutions - Biologicals complement a systems approach to increasing yield
Breeding Biotechnology Biologicals Chemistry Agronomics
Highest yielding
genetics for the
environment:
conventional
breeding gains
and natural
disease
resistance
Complementary agronomic and yield enhancing traits
Derived from natural materials or based on natural processes to support plant health and pest protection
Seed treatments and selective chemistries protect the crop from pests, weeds and diseases
Optimizing farm management practices, including rotations, soil management, cover crops
9
Location based performance
Performance under
insect/disease pressure
Approved
Global Corn BreedingGlobal Environment & Modeling
Monsanto Company Confidential
Soil & environmental interactions
(within field variability)
Macro-zone based performance
Extensive field testing on a scale never seen before for microbials
One-of-a-Kind R&D approach Leveraging the combined strengths of Novozymes and Monsanto
Alliance’s unique “Field Yield Testing” approach tests 1000’s of microbials across 10’s of
thousands of locations
• Microbes are isolated from diverse environments and for
each the genus, species and molecular sequence are
identified
• >16.000 new diverse isolates and ~5.800 fermentations
delivered for seed treatment between 2013-2016 field trials.
• Microbials applied on corn, soy and wheat seed and tested in
real soils to see if they can compete in a natural environment
while also colonizing roots
• Linking field data to performance & genomes to accelerate
innovation with complete data mining efforts to understand
performance drivers
• Early results are promising - Corn microbial yield product
concept advanced to Phase 2 and promising hits in soy.
A unique transformational R&D program for broad acre product development and prescriptive deployment
Monsanto’s field testing network is the largest in the world
Significant early breakthroughs have demonstrated the promising future of The BioAg Alliance.
Acceleron® B-300 SAT – A breakthrough corn inoculant
11
Trials demonstrated significant corn root development
Acceleron SAS +
Acceleron B-300 SAT
Acceleron
SAS Control
Field Testing Results show improved nutrient access
200
205
210
2 year average yield data across
78 locations supports >3 BU/AC
average yield advantage
Acceleron SAS1
Control
Acceleron SAS1 +
Acceleron B-300 SAT
First microbial on-seed inoculant having more than two years on-seed stability and consistent yield benefit
Represents the first Alliance microbial seed treatment for corn
Global expansion in progress with the potential to penetrate >90M acres– making it one of the largest biological products in the ag industry
1
2